Datamonitor Release: Infographic: "American Diabetes Association 2013" - The Impact on Key Drugs...
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Following Chicago’s annual gathering of the American Diabetes Association, use our infographic to quickly visualize the impact of study results on key drugs. Compare the conference outcome for a number of new market entrants and leading pipeline treatments, including Eli Lilly‘s experimental drug dulaglutide and Sanofi’s investigational new insulin U300, with the following insight:
- Perception Shift Score based on expert Analyst opinion
- Historic vs. Projected Revenue comparing 2012 and 2023 performance
- Drug Summaries based on highlights of presentation data
Download your free infographic here
For any questions regarding this infographic, or our diabetes analysis in general, please contact our team.
Datamonitor Healthcare
www.datamonitorhealthcare.com
Help employers find you! Check out all the jobs and post your resume.
Following Chicago’s annual gathering of the American Diabetes Association, use our infographic to quickly visualize the impact of study results on key drugs. Compare the conference outcome for a number of new market entrants and leading pipeline treatments, including Eli Lilly‘s experimental drug dulaglutide and Sanofi’s investigational new insulin U300, with the following insight:
- Perception Shift Score based on expert Analyst opinion
- Historic vs. Projected Revenue comparing 2012 and 2023 performance
- Drug Summaries based on highlights of presentation data
Download your free infographic here
For any questions regarding this infographic, or our diabetes analysis in general, please contact our team.
Datamonitor Healthcare
www.datamonitorhealthcare.com
Help employers find you! Check out all the jobs and post your resume.